Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Shopify
SHOP
|
+$1.7B |
| 2 |
PepsiCo
PEP
|
+$975M |
| 3 |
Futu Holdings
FUTU
|
+$654M |
| 4 |
Ferrari
RACE
|
+$604M |
| 5 |
Mercado Libre
MELI
|
+$598M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.28B |
| 3 |
Constellation Brands
STZ
|
+$1.03B |
| 4 |
EOG Resources
EOG
|
+$913M |
| 5 |
Amgen
AMGN
|
+$806M |
Sector Composition
| 1 | Technology | 19.95% |
| 2 | Healthcare | 14.72% |
| 3 | Communication Services | 14.69% |
| 4 | Consumer Discretionary | 13.44% |
| 5 | Financials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Nutrien
NTR
$27.7B
| $190M | 0.04% |
3,131,858
-2,329,783
| -43% | -$141M |
|
252
PAR Technology
PAR
$1.79B
| $185M | 0.04% |
2,648,851
+679,291
| +34% | +$47.5M |
|
|
IBTX
253
DELISTED
Independent Bank Group, Inc.
IBTX
| $184M | 0.04% |
2,484,346
+634,700
| +34% | +$47M |
|
|
XM
254
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $180M | 0.04% |
4,703,223
+1,536,614
| +49% | +$58.8M |
|
|
AMTI
255
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $180M | 0.04% |
3,930,356
+1,151,525
| +41% | +$52.7M |
|
256
Merck
MRK
$207B
| $180M | 0.04% |
2,310,259
-3,300,114
| -59% | -$257M |
|
257
Haemonetics
HAE
$2.51B
| $179M | 0.04% |
2,679,336
-3,538,162
| -57% | -$236M |
|
|
NVRO
258
DELISTED
NEVRO CORP.
NVRO
| $177M | 0.04% |
1,066,185
+156,379
| +17% | +$25.9M |
|
259
Olo Inc
OLO
| $175M | 0.04% |
4,691,500
+1,271,500
| +37% | +$47.5M |
|
260
New York Times
NYT
$9.59B
| $173M | 0.04% |
3,971,995
-121,492
| -3% | -$5.29M |
|
261
Health Catalyst
HCAT
$220M
| $171M | 0.04% |
3,089,217
+94,917
| +3% | +$5.27M |
|
262
Asana
ASAN
$3.12B
| $169M | 0.04% |
2,724,132
+223,489
| +9% | +$13.9M |
|
|
RDS.A
263
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $163M | 0.04% |
4,023,686
-483,786
| -11% | -$19.5M |
|
|
OCFT
264
OneConnect Financial Technology
OCFT
$281M
| $161M | 0.04% |
1,340,570
+183,573
| +16% | +$22.1M |
|
265
SouthState Bank Corporation
SSB
$10.2B
| $159M | 0.04% |
1,948,078
+155,623
| +9% | +$12.7M |
|
266
Globus Medical
GMED
$7.93B
| $159M | 0.04% |
2,053,234
| – | – |
|
|
VGR
267
DELISTED
Vector Group Ltd.
VGR
| $159M | 0.04% |
15,849,401
+87,764
| +0.6% | +$880K |
|
268
Americold
COLD
$3.93B
| $153M | 0.04% |
4,037,013
-692,697
| -15% | -$26.2M |
|
269
Darden Restaurants
DRI
$24.8B
| $148M | 0.03% |
1,010,816
-831,426
| -45% | -$121M |
|
270
Rapid7
RPD
$1.27B
| $145M | 0.03% |
1,527,366
+854,866
| +127% | +$80.9M |
|
271
AppFolio
APPF
$9.9B
| $144M | 0.03% |
1,020,791
-4,664
| -0.5% | -$659K |
|
272
Allogene Therapeutics
ALLO
$251M
| $141M | 0.03% |
5,404,300
-7,259,713
| -57% | -$189M |
|
273
Johnson & Johnson
JNJ
$429B
| $136M | 0.03% |
827,380
-603,571
| -42% | -$99.4M |
|
274
Kimberly-Clark
KMB
$42.5B
| $136M | 0.03% |
1,014,891
-1,054
| -0.1% | -$141K |
|
|
AVLR
275
DELISTED
Avalara, Inc.
AVLR
| $136M | 0.03% |
838,436
-54,697
| -6% | -$8.85M |
|